Rhiannon Dowla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rhiannon Dowla has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Kieron Rooney
University of Sydney
3 shared publications - Yorgi Mavros
University of Sydney, Sydney, New South Wales, Australia
3 shared publications - Bridin Murnion
Sydney Medical School, Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia
2 shared publications - Elizabeth A. Cayanan
Department of Medicine and Health, Susan Wakil Health Building, University of Sydney, Sydney, Australia The Woolcock Institute of Medical Research, Glebe, Australia
2 shared publications Bridin Murnion
Faculty of Medicine and Health, Susan Wakil Health Building, University of Sydney, Sydney, Australia
1 shared publicationCarolyn Stubley
We Help Ourselves, Lilyfield, Australia
1 shared publication
Latest Publications
- Open Access
- 1 October 2026
- Published by Taylor & Francis in Substance Abuse and Rehabilitation
- Vol. ume 17, 1-17
Non-Pharmacological Treatment Approaches for People with Concurrent Chronic Pain and Opioid Use Disorder: A Scoping Review
Background: Almost half (44%) of people receiving pharmacotherapy for opioid use disorder (OUD) have comorbid chronic non-cancer pain (CNCP). Non-pharmacological treatments for pain management are recommended alongside pharmacotherapy, yet evidence regarding their effectiveness, feasibility, acceptability, and affordability remains limited, warranting an updated review of current evidence. Methods: A scoping review was conducted following JBI methodology and PRISMA-ScR guidelines. Four databases were searched in November 2025, while a grey literature search was conducted in Google Scholar in December 2025 for publications on non-pharmacological interventions for adults with concurrent CNCP and OUD. Eligible publications were screened independently, data were extracted using a standardised form, and findings were synthesised narratively. Results: 35 publications were included, representing 15 publications from 13 primary studies and 20 protocols. Findings from the 13 primary studies primarily examined psychosocial, physical activity, and multimodal interventions, with psychosocial interventions being the most frequently studied. Overall, non-pharmacological interventions showed potential benefits in reducing pain, opioid craving, and substance use. Feasibility varied across intervention modalities, while acceptability was generally favourable among the 7 primary studies that assessed it. Conclusion: This scoping review mapped the available evidence on psychosocial, physical, and multimodal approaches for managing co-occurring CNCP and OUD. However, current evidence remains limited and insufficient to determine comparative effectiveness. The growing number of recently completed and ongoing trials indicates an expanding evidence base that will support more robust future evaluation and inform clinical practice.
- 1 October 2026
- Published by Taylor & Francis in Substance Abuse and Rehabilitation
- Vol. ume 17, 1-17
Open AccessNon-Pharmacological Treatment Approaches for People with Concurrent Chronic Pain and Opioid Use Disorder: A Scoping Review
Background: Almost half (44%) of people receiving pharmacotherapy for opioid use disorder (OUD) have comorbid chronic non-cancer pain (CNCP). Non-pharmacological treatments for pain management are recommended alongside pharmacotherapy, yet evidence regarding their effectiveness, feasibility, acceptability, and affordability remains limited, warranting an updated review of current evidence. Methods: A scoping review was conducted following JBI methodology and PRISMA-ScR guidelines. Four databases were searched in November 2025, while a grey literature search was conducted in Google Scholar in December 2025 for publications on non-pharmacological interventions for adults with concurrent CNCP and OUD. Eligible publications were screened independently, data were extracted using a standardised form, and findings were synthesised narratively. Results: 35 publications were included, representing 15 publications from 13 primary studies and 20 protocols. Findings from the 13 primary studies primarily examined psychosocial, physical activity, and multimodal interventions, with psychosocial interventions being the most frequently studied. Overall, non-pharmacological interventions showed potential benefits in reducing pain, opioid craving, and substance use. Feasibility varied across intervention modalities, while acceptability was generally favourable among the 7 primary studies that assessed it. Conclusion: This scoping review mapped the available evidence on psychosocial, physical, and multimodal approaches for managing co-occurring CNCP and OUD. However, current evidence remains limited and insufficient to determine comparative effectiveness. The growing number of recently completed and ongoing trials indicates an expanding evidence base that will support more robust future evaluation and inform clinical practice.
- Open Access
- 1 December 2025
- Published by KEAI Publishing in Advanced Exercise and Health Science
- Vol. 2 (4) , 293-300
Exercise is therapy: A cross-sectional study evaluation of the impact of exercise on affect, arousal and distress in an inpatient mental health service
- 1 December 2025
- Published by KEAI Publishing in Advanced Exercise and Health Science
- Vol. 2 (4) , 293-300
Open AccessExercise is therapy: A cross-sectional study evaluation of the impact of exercise on affect, arousal and distress in an inpatient mental health service
- 26 October 2022
- Published by Medip Academy in International Journal of Clinical Trials
- Vol. 9 (4) , 279-285
Fitness in recovery: impact of exercise in people with substance use disorder in residential treatment
Background: Opioid use disorder has the lowest quality of life (QOL) and highest disease burden of all substance use disorders (SUD). While opioid treatment does lead to initial improvements in QOL it remains below that of the general population. The integration of exercise programs as an adjunct therapy for SUD is gaining popularity. Previous reviews have indicated that exercise offers significant benefits for QOL, however the evidence in an opioid treatment population is lacking. This study will investigate the impact of a 12-week exercise intervention on QOL and mood in a residential opioid treatment rehabilitation program.Methods: This is a 12-week single arm intervention with a natural history control. Participants will complete a baseline screening assessing QOL, mood and exercise habits and those who meet criteria for exercise participation will complete an exercise assessment. The exercise program will be delivered twice per week as part of the group therapy program. Exercise sessions will run for approximately 40 minutes and be at an intensity selected by each of the participants.Conclusions: A recent review indicated that two sessions of exercise for a minimum of 12 weeks leads to an improvement in QOL in general SUD, however, to date minimal studies have been completed in people receiving opioid agonist treatment. Hence, this will be the first study to our knowledge, assessing the role of exercise as an adjunct treatment for QOL in this population.Trial Registration: This trial has been registered with the Australian New Zealand clinical trials registry ACTRN12622000213741.
- 26 October 2022
- Published by Medip Academy in International Journal of Clinical Trials
- Vol. 9 (4) , 279-285
Fitness in recovery: impact of exercise in people with substance use disorder in residential treatment
Background: Opioid use disorder has the lowest quality of life (QOL) and highest disease burden of all substance use disorders (SUD). While opioid treatment does lead to initial improvements in QOL it remains below that of the general population. The integration of exercise programs as an adjunct therapy for SUD is gaining popularity. Previous reviews have indicated that exercise offers significant benefits for QOL, however the evidence in an opioid treatment population is lacking. This study will investigate the impact of a 12-week exercise intervention on QOL and mood in a residential opioid treatment rehabilitation program.Methods: This is a 12-week single arm intervention with a natural history control. Participants will complete a baseline screening assessing QOL, mood and exercise habits and those who meet criteria for exercise participation will complete an exercise assessment. The exercise program will be delivered twice per week as part of the group therapy program. Exercise sessions will run for approximately 40 minutes and be at an intensity selected by each of the participants.Conclusions: A recent review indicated that two sessions of exercise for a minimum of 12 weeks leads to an improvement in QOL in general SUD, however, to date minimal studies have been completed in people receiving opioid agonist treatment. Hence, this will be the first study to our knowledge, assessing the role of exercise as an adjunct treatment for QOL in this population.Trial Registration: This trial has been registered with the Australian New Zealand clinical trials registry ACTRN12622000213741.
- 30 March 2022
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 57 (6) , 911-928
The Effectiveness of Exercise as an Adjunct Intervention to Improve Quality of Life and Mood in Substance Use Disorder: A Systematic Review
Introduction: Quality of life and affective outcomes offer a perspective of the burden of disease experienced by people with substance use disorder. This can be considered an alternative measure of substance use disorder severity. This review aims to evaluate the impact of exercise as a novel intervention on quality of life and affect in substance use disorder. Method: Medline, CINAHL, Amed, Web of Science core collections, Embase, PsychINFO and SportDISCUS databases were searched from inception to August 2021 for studies that assessed the impact of exercise on mood, depression, anxiety and quality of life outcomes in substance use disorder. Exercise interventions of any duration were included. Results: Forty-two studies met the inclusion criteria. Quality of life scores improved with larger effects seen in studies with two or more sessions per week. Depression and anxiety scores decreased, with 19 of the 25 data sets reporting a reduction in depression (effect size 0.2–1.86) and 13 of the 17 data sets reporting a reduction in anxiety (effect sizes 0.2–1.42). Mood improved in six of the seven data sets reviewed with effect sizes ranging from 0.34 to 1.13. Discussion: Included studies had numerous methodological flaws therefore results need to be interpreted with caution. Further research needs to be completed with more rigorous methodologies to support these results. Conclusions: Results indicate promising responses to exercise as a novel intervention for quality of life and mood in substance use disorder, however further research of high methodological quality is needed to confirm.
- 30 March 2022
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 57 (6) , 911-928
The Effectiveness of Exercise as an Adjunct Intervention to Improve Quality of Life and Mood in Substance Use Disorder: A Systematic Review
Introduction: Quality of life and affective outcomes offer a perspective of the burden of disease experienced by people with substance use disorder. This can be considered an alternative measure of substance use disorder severity. This review aims to evaluate the impact of exercise as a novel intervention on quality of life and affect in substance use disorder. Method: Medline, CINAHL, Amed, Web of Science core collections, Embase, PsychINFO and SportDISCUS databases were searched from inception to August 2021 for studies that assessed the impact of exercise on mood, depression, anxiety and quality of life outcomes in substance use disorder. Exercise interventions of any duration were included. Results: Forty-two studies met the inclusion criteria. Quality of life scores improved with larger effects seen in studies with two or more sessions per week. Depression and anxiety scores decreased, with 19 of the 25 data sets reporting a reduction in depression (effect size 0.2–1.86) and 13 of the 17 data sets reporting a reduction in anxiety (effect sizes 0.2–1.42). Mood improved in six of the seven data sets reviewed with effect sizes ranging from 0.34 to 1.13. Discussion: Included studies had numerous methodological flaws therefore results need to be interpreted with caution. Further research needs to be completed with more rigorous methodologies to support these results. Conclusions: Results indicate promising responses to exercise as a novel intervention for quality of life and mood in substance use disorder, however further research of high methodological quality is needed to confirm.